Arrowhead Pharmaceuticals Aktie
12,89
EUR
+1,39
EUR
+12,04
%
14,41
USD
+0,38
USD
+2,71
%
Werbung
Arrowhead Pharmaceuticals Aktie Analyse
07.09.18 | Arrowhead Pharmaceuticals Buy | B. Riley FBR | |
06.09.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
08.08.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
02.07.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
09.05.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
10.11.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
19.05.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets |
Werbung
Werbung